Retrieve available abstracts of 15 articles: HTML format
Single Articles
August 2025
PAN S, Deng Y, Fu J, Zhang Y, et al [Retracted] N6?methyladenosine upregulates miR?181d?5p in exosomes derived from
cancer?associated fibroblasts to inhibit 5?FU sensitivity by targeting NCALD in
colorectal cancer.
Int J Oncol. 2025;67:62. PubMedAbstract available
March 2025
TAN S, Li S, Xia L, Jiang X, et al Long non?coding RNA ABHD11?AS1 inhibits colorectal cancer progression through
interacting with EGFR to suppress the EGFR/ERK signaling pathway.
Int J Oncol. 2025;66:20. PubMedAbstract available
YANG Z, Chen Y, Wei X, Wu D, et al [Corrigendum] Upregulated NTF4 in colorectal cancer promotes tumor development
via regulating autophagy.
Int J Oncol. 2025;66:19. PubMedAbstract available
JIN Z, Li Y, Yi H, Wang M, et al Pathogenetic development, diagnosis and clinical therapeutic approaches for liver
metastasis from colorectal cancer (Review).
Int J Oncol. 2025;66:22. PubMedAbstract available
LI Z, Deng L, Cheng M, Ye X, et al Emerging role of bile acids in colorectal liver metastasis: From molecular
mechanism to clinical significance (Review).
Int J Oncol. 2025;66:24. PubMedAbstract available
February 2025
ZHANG Y, Wang J, Quan R, Lyu L, et al circ_0004662 contributes to colorectal cancer progression by interacting with
hnRNPM.
Int J Oncol. 2025;66:14. PubMedAbstract available
January 2025
PATLOLLA JMR, Zhang Y, Li Q, Steele VE, et al [Corrigendum] Anti?carcinogenic properties of omeprazole against human colon
cancer cells and azoxymethane?induced colonic aberrant crypt foci formation in
rats.
Int J Oncol. 2025;66:3. PubMedAbstract available
December 2024
NAKANO Y, Masuda T, Sakamoto T, Tanaka N, et al SHARPIN is a novel gene of colorectal cancer that promotes tumor growth
potentially via inhibition of p53 expression.
Int J Oncol. 2024;65:113. PubMedAbstract available
October 2024
LI H, Li D, Meng N [Retracted] Effects of RUNX3 mediated Notch signaling pathway on biological
characteristics of colorectal cancer cells.
Int J Oncol. 2024;65:91. PubMedAbstract available
WU K, Wu QX, Yuan SX, Wang DX, et al [Corrigendum] The role of IGFBP?5 in mediating the anti?proliferation effect of
tetrandrine in human colon cancer cells.
Int J Oncol. 2024;65:93. PubMedAbstract available
TONG G, Shen Y, Li H, Qian H, et al NLRC4, inflammation and colorectal cancer (Review).
Int J Oncol. 2024;65:99. PubMedAbstract available
September 2024
ZENG W, Liu H, Mao Y, Jiang S, et al Myeloid?derived suppressor cells: Key immunosuppressive regulators and
therapeutic targets in colorectal cancer (Review).
Int J Oncol. 2024;65:85. PubMedAbstract available
June 2024
KIM BR, Kim DY, Tran NL, Kim BG, et al Daunorubicin induces GLI1?dependent apoptosis in colorectal cancer cell lines.
Int J Oncol. 2024;64:66. PubMedAbstract available
April 2024
KAKAFIKA MG, Lyta AA, Gavriilidis GI, Tsiftsoglou SA, et al Targeting mitochondrial bioenergetics by combination treatment with imatinib and
dichloroacetate in human erythroleukemic K?562 and colorectal HCT?116 cancer
cells.
Int J Oncol. 2024;64:42. PubMedAbstract available
SUN J, Chen S, Zang D, Sun H, et al Butyrate as a promising therapeutic target in cancer: From pathogenesis to clinic
(Review).
Int J Oncol. 2024;64:44. PubMedAbstract available